T. Rowe Price Investment Management, Inc. 13D and 13G filings for Immunocore Holdings plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:28 pm Purchase | 2024-09-30 | 13G | Immunocore Holdings plc IMCR | T. Rowe Price Investment Management, Inc. | 6,499,835 13.000% | 1,334,936 (+25.85%) | Filing |
| 2024-09-10 1:49 pm Purchase | 2024-08-31 | 13G | Immunocore Holdings plc IMCR | T. Rowe Price Investment Management, Inc. | 5,164,899 10.300% | 5,164,899 (New Position) | Filing |